Health Care & Life Sciences » Pharmaceuticals | Shanghai Shyndec Pharmaceutical Co. Ltd.

Shanghai Shyndec Pharmaceutical Co. Ltd. A | Mutual Funds

Mutual Funds that own Shanghai Shyndec Pharmaceutical Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
6,400,316
1.11%
1,361,960
8.94%
12/31/2017
5,080,314
0.88%
4,815,134
2.87%
12/31/2017
HSBC Jintrust Large Cap Equity Fund
4,286,458
0.75%
4,286,458
0.69%
12/31/2017
3,909,799
0.68%
3,909,799
0.49%
12/31/2017
LC Value Discovery Equity Fund
3,199,970
0.56%
3,199,970
0.57%
12/31/2017
2,612,888
0.45%
-354,994
1.45%
12/31/2017
2,087,300
0.36%
2,087,300
0.75%
12/31/2017
Rongtong Leading Growth Equity Fund
1,902,689
0.33%
-1,047,037
0.57%
12/31/2017
1,365,946
0.24%
-2,278,900
0.98%
12/31/2017
1,000,000
0.17%
-1,000,120
1.59%
12/31/2017

About Shanghai Shyndec Pharmaceutical Co.

View Profile
Address
1320 Beijing West Road
Shanghai Shanghai 200040
China
Employees -
Website http://www.shyndec.com
Updated 07/08/2019
Shanghai Shyndec Pharmaceutical Co., Ltd. principally engages in the research, development, manufacturing, and sale of pharmaceutical products. Its product range covers anti-infective drugs, cardiovascular and cerebrovascular drugs, anti-tumour drugs, anaesthetic psychotropic drugs, as well as metabolic and endocrine drugs. The company was founded in 1996 and is headquartered in Shanghai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.